Health state utilities for skeletal-related events secondary to bone metastases
Louis S. Matza, Jean‐Jacques Body(Université Libre de Bruxelles), Karen Chung(Viking Therapeutics (United States)), Andrew Palsgrove(Health Outcomes Solutions (United States)), Kate Van Brunt(Health Outcomes Solutions (United States)), Evan Davies(Health Outcomes Solutions (United States)), John Brazier(Institut de la Vision), Ada Braun(National Cancer Centre Japan), Brooke M. Currie(Health Outcomes Solutions (United States))
Cited by 32
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
|Value in Health|2004|695
Deriving a Preference-Based Single Index from the UK SF-36 Health Survey
|Journal of Clinical Epidemiology|1998|691
The Factor Structure of the SF-36 Health Survey in 10 Countries
|Journal of Clinical Epidemiology|1998|657